Concepedia

Bacillus Calmette-Guérin versus mitomycin intravesical therapy in superficial bladder cancer

F.M.J. Debruyne, P.M. van der Meijden, J. Alfred Witjes, M.P.H. Franssen, P. A. Steerenberg, W.H. DeJong, John Read, M.J.W. van Leeuwen, B. Hammond, Richard Sylvester

Urology · 1992 · 13 citations · 18 references

DOI

Concepts

References

18

Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer

Steven A. Rosenberg, Michael T. Lotze, Linda Muul et al. · New England Journal of Medicine · 1985 · 2.6K citations

, , +15

Risks and Benefits of Repeated Courses of Intravesical Bacillus Calmette-guerin Therapy for Superficial Bladder Cancer

William J. Catàlona, M’Liss A. Hudson, Daniel Gillen et al. · The Journal of Urology · 1987 · 289 citations

, , +6

Bacillus Calmette-Guérin therapy alters the progression of superficial bladder cancer.

H.W. Herr, Vincent P. Laudone, Robert A. Badalament et al. · Journal of Clinical Oncology · 1988 · 287 citations

, , +13

A prospective randomized trial of maintenance versus nonmaintenance intravesical bacillus Calmette-Guérin therapy of superficial bladder cancer.

Robert A. Badalament, H.W. Herr, George Y. Wong et al. · Journal of Clinical Oncology · 1987 · 230 citations

, , +10

Intravesical Bacillus Calmette-Guérin therapy for murine bladder tumors: initiation of the response by fibronectin-mediated attachment of Bacillus Calmette-Guérin.

Timothy L. Ratliff, James O. Palmer, Janet Mcgarr et al. · PubMed · 1987 · 159 citations

, , +16